1. Bates GP, Harper PS, Jones AL, editors (2002) Huntington's Disease. 3rd edition. Oxford: Oxford University Press.
2. StrongTV, TagleDA, ValdesJM, ElmerLW, BoehmK, et al. (1993) Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet 5: 259–265.
3. LiSH, SchillingG, YoungWSd, LiXJ, MargolisRL, et al. (1993) Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11: 985–993.
4. ImarisioS, CarmichaelJ, KorolchukV, ChenCW, SaikiS, et al. (2008) Huntington's disease: from pathology and genetics to potential therapies. Biochem J 412: 191–209.
5. LiW, SerpellLC, CarterWJ, RubinszteinDC, HuntingtonJA (2006) Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein. J Biol Chem 281: 15916–15922.
6. HarjesP, WankerEE (2003) The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 28: 425–433.
7. GutekunstCA, LiSH, YiH, MulroyJS, KuemmerleS, et al. (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19: 2522–2534.
8. SathasivamK, HobbsC, TurmaineM, MangiariniL, MahalA, et al. (1999) Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 8: 813–822.
9. MoffittH, McPhailGD, WoodmanB, HobbsC, BatesGP (2009) Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease. PLoS One 4: e8025.
10. van der BurgJM, BjorkqvistM, BrundinP (2009) Beyond the brain: widespread pathology in Huntington's disease. Lancet Neurol 8: 765–774.
11. SorensenSA, FengerK (1992) Causes of death in patients with Huntington's disease and in unaffected first degree relatives. J Med Genet 29: 911–914.
12. ChiuE, AlexanderL (1982) Causes of death in Huntington's disease. Med J Aust 1: 153.
13. LanskaDJ, LavineL, LanskaMJ, SchoenbergBS (1988) Huntington's disease mortality in the United States. Neurology 38: 769–772.
14. AndrichJ, SchmitzT, SaftC, PostertT, KrausP, et al. (2002) Autonomic nervous system function in Huntington's disease. J Neurol Neurosurg Psychiatry 72: 726–731.
15. HasselbalchSG, ObergG, SorensenSA, AndersenAR, WaldemarG, et al. (1992) Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. J Neurol Neurosurg Psychiatry 55: 1018–1023.
16. MelikZ, KobalJ, CankarK, StruclM (2012) Microcirculation response to local cooling in patients with Huntington's disease. J Neurol 259: 921–928.
17. BarKJ, BoettgerMK, AndrichJ, EpplenJT, FischerF, et al. (2008) Cardiovagal modulation upon postural change is altered in Huntington's disease. Eur J Neurol 15: 869–871.
18. SanbeA, OsinskaH, VillaC, GulickJ, KlevitskyR, et al. (2005) Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 102: 13592–13597.
19. MaloyanA, SanbeA, OsinskaH, WestfallM, RobinsonD, et al. (2005) Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 112: 3451–3461.
20. MillucciL, PaccagniniE, GhezziL, BernardiniG, BraconiD, et al. (2011) Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. PLoS One 6: e21870.
21. PattisonJS, SanbeA, MaloyanA, OsinskaH, KlevitskyR, et al. (2008) Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation 117: 2743–2751.
22. MangiariniL, SathasivamK, SellerM, CozensB, HarperA, et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493–506.
23. LinCH, Tallaksen-GreeneS, ChienWM, CearleyJA, JacksonWS, et al. (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet 10: 137–144.
24. WoodmanB, ButlerR, LandlesC, LuptonMK, TseJ, et al. (2007) The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypes. Brain Res Bull 72: 83–97.
25. SathasivamK, NeuederA, GipsonTA, LandlesC, BenjaminAC, et al. (2013) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A 110: 2366–2370.
26. WoodNI, SawiakSJ, BuonincontriG, NiuY, KaneAD, et al. (2012) Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington's disease. J Huntingtons Dis 1: 57–64.
27. SchneiderM, KostinS, StromCC, AplinM, LyngbaekS, et al. (2007) S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc Res 75: 40–50.
28. ChenHH, MullettSJ, StewartAF (2004) Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes. J Biol Chem 279: 30800–30806.
29. ZuccatoC, CattaneoE (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5: 311–322.
30. BennCL, FoxH, BatesGP (2008) Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease. Mol Neurodegener 3: 17.
31. KuhnA, GoldsteinDR, HodgesA, StrandAD, SengstagT, et al. (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16: 1845–1861.
32. StrandAD, AragakiAK, ShawD, BirdT, HoltonJ, et al. (2005) Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum Mol Genet 14: 1863–1876.
33. YaoJA, HussainW, PatelP, PetersNS, BoydenPA, et al. (2003) Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts. Circ Res 92: 437–443.
34. GutsteinDE, MorleyGE, TamaddonH, VaidyaD, SchneiderMD, et al. (2001) Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 88: 333–339.
35. LernerDL, YamadaKA, SchuesslerRB, SaffitzJE (2000) Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 101: 547–552.
36. AndoM, KatareRG, KakinumaY, ZhangD, YamasakiF, et al. (2005) Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 112: 164–170.
37. IwanagaK, WakabayashiK, YoshimotoM, TomitaI, SatohH, et al. (1999) Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 52: 1269–1271.
38. RysevaiteK, SaburkinaI, PauzieneN, NoujaimSF, JalifeJ, et al. (2011) Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart. Heart Rhythm 8: 448–454.
39. RichardsonRJ, GrkovicI, AndersonCR (2003) Immunohistochemical analysis of intracardiac ganglia of the rat heart. Cell Tissue Res 314: 337–350.
40. YangD, WangCE, ZhaoB, LiW, OuyangZ, et al. (2010) Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet 19: 3983–3994.
41. GardJJ, YamadaK, GreenKG, EloffBC, RosenbaumDS, et al. (2005) Remodeling of gap junctions and slow conduction in a mouse model of desmin-related cardiomyopathy. Cardiovasc Res 67: 539–547.
42. OliveM, GoldfarbL, MorenoD, LaforetE, DagvadorjA, et al. (2004) Desmin-related myopathy: clinical, electrophysiological, radiological, neuropathological and genetic studies. J Neurol Sci 219: 125–137.
43. SathasivamK, LaneA, LegleiterJ, WarleyA, WoodmanB, et al. (2010) Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum Mol Genet 19: 65–78.
44. HayDG, SathasivamK, TobabenS, StahlB, MarberM, et al. (2004) Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum Mol Genet 13: 1389–1405.
45. LabbadiaJ, CunliffeH, WeissA, KatsyubaE, SathasivamK, et al. (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J Clin Invest 121: 3306–3319.
46. YusufSW, SolhpourA, BanchsJ, Lopez-MatteiJC, DurandJB, et al. (2014) Cardiac amyloidosis. Expert Rev Cardiovasc Ther 12: 265–277.
47. MelkaniGC, TrujilloAS, RamosR, BodmerR, BernsteinSI, et al. (2013) Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. PLoS Genet 9: e1004024.
48. MihmMJ, AmannDM, SchanbacherBL, AltschuldRA, BauerJA, et al. (2007) Cardiac dysfunction in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 25: 297–308.
49. SchipsTG, WietelmannA, HohnK, SchimanskiS, WaltherP, et al. (2011) FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovasc Res 91: 587–597.
50. TamakiY, IwanagaY, NiizumaS, KawashimaT, KatoT, et al. (2013) Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts. J Mol Cell Cardiol 57: 72–81.
51. PereiraVH, CerqueiraJJ, PalhaJA, SousaN (2013) Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int J Cardiol 166: 30–37.
52. HeierCR, SattaR, LutzC, DiDonatoCJ (2010) Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum Mol Genet 19: 3906–3918.
53. KobalJ, MelikZ, CankarK, BajrovicFF, MeglicB, et al. (2010) Autonomic dysfunction in presymptomatic and early symptomatic Huntington's disease. Acta Neurol Scand 121: 392–399.
54. KiriazisH, JenningsNL, DavernP, LambertG, SuY, et al. (2012) Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. J Physiol 590: 5845–5860.
55. SaffitzJE (2005) Dependence of electrical coupling on mechanical coupling in cardiac myocytes: insights gained from cardiomyopathies caused by defects in cell-cell connections. Ann N Y Acad Sci 1047: 336–344.
56. SaffitzJE, HamesKY, KannoS (2007) Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol 218: 65–71.
57. DupontE, MatsushitaT, KabaRA, VozziC, CoppenSR, et al. (2001) Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol 33: 359–371.
58. DaviesSW, TurmaineM, CozensBA, DiFigliaM, SharpAH, et al. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537–548.
59. LiH, LiSH, ChengAL, MangiariniL, BatesGP, et al. (1999) Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum Mol Genet 8: 1227–1236.
60. ChaJH (2007) Transcriptional signatures in Huntington's disease. Prog Neurobiol 83: 228–248.
61. DoganI, EickhoffSB, SchulzJB, ShahNJ, LairdAR, et al. (2013) Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis. Neurodegener Dis 12: 23–35.
62. HocklyE, WoodmanB, MahalA, LewisCM, BatesG (2003) Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Res Bull 61: 469–479.
63. MielcarekM, BennCL, FranklinSA, SmithDL, WoodmanB, et al. (2011) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease. PLoS One 6: e27746.
64. HuJ, GeH, NewmanM, LiuK (2012) OSA: a fast and accurate alignment tool for RNA-Seq. Bioinformatics 28: 1933–1934.
65. AndersS, HuberW (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106.
66. LangfelderP, HorvathS (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
67. LangfelderP, ZhangB, HorvathS (2008) Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics. 24: 719–720.
68. LangfelderP, LuoR, OldhamMC, HorvathS (2011) Is my network module preserved and reproducible? PLoS Comput Biol 7: e1001057.
69. Huang daW, ShermanBT, LempickiRA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57.
70. ProttiA, DongX, SirkerA, BotnarR, ShahAM (2012) MRI-based prediction of adverse cardiac remodeling after murine myocardial infarction. Am J Physiol Heart Circ Physiol 303: H309–H314.
71. ProttiA, SirkerA, ShahAM, BotnarR (2010) Late gadolinium enhancement of acute myocardial infarction in mice at 7T: cine-FLASH versus inversion recovery. J Magn Reson Imaging 32: 878–886.